1. Sato, Takashi, Soejima, Kenzo, Arai, Eri, Kanai, Yae, Betsuyaku, Tomoko. 2015. Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer. In Oncology reports, 34, 1137-45. doi:10.3892/or.2015.4082. https://pubmed.ncbi.nlm.nih.gov/26134684/
2. Chen, Aifeng, Ding, Shibiao, Shen, Xiaoqiang, Lin, Xuai. 2021. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma. In Computational and mathematical methods in medicine, 2021, 9932088. doi:10.1155/2021/9932088. https://pubmed.ncbi.nlm.nih.gov/34367321/
3. Swiatnicki, Matthew R, Rennhack, Jonathan P, Ortiz, Mylena M O, O'Reilly, Sandra, Andrechek, Eran R. 2022. Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH. In PLoS genetics, 18, e1010362. doi:10.1371/journal.pgen.1010362. https://pubmed.ncbi.nlm.nih.gov/36054194/
4. Bujko, Mateusz, Kober, Paulina, Statkiewicz, Małgorzata, Ostrowski, Jerzy, Siedlecki, Janusz Aleksander. 2017. Downregulation of PTPRH (Sap-1) in colorectal tumors. In International journal of oncology, 51, 841-850. doi:10.3892/ijo.2017.4068. https://pubmed.ncbi.nlm.nih.gov/28713969/
5. Jönsson, Jenny-Maria, Bartuma, Katarina, Dominguez-Valentin, Mev, Jönsson, Göran, Nilbert, Mef. . Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome. In Familial cancer, 13, 537-45. doi:10.1007/s10689-014-9728-1. https://pubmed.ncbi.nlm.nih.gov/24848881/
6. Wälchli, Sébastien, Espanel, Xavier, Hooft van Huijsduijnen, Rob. . Sap-1/PTPRH activity is regulated by reversible dimerization. In Biochemical and biophysical research communications, 331, 497-502. doi:. https://pubmed.ncbi.nlm.nih.gov/15850787/
7. He, Zhengxi, Su, Jun, Liu, Qing, Shen, Liangfang, Li, Haoyu. . Biological function of protein tyrosine phosphatase H-type receptor and its progress in tumor. In Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 45, 61-67. doi:10.11817/j.issn.1672-7347.2020.180612. https://pubmed.ncbi.nlm.nih.gov/32132299/
智鼠故事 
